Description

Drostanolone Propionate 100 mg/ml by Swiss Healthcare contains Drostanolone Propionate, a fast-acting injectable anabolic-androgenic steroid (AAS) historically used in clinical settings to treat breast cancer and studied in modern research for its ability to support lean muscle retention, strength, and hardening effects without significant estrogenic activity.

Drostanolone is a DHT-derived compound known for its strong binding to androgen receptors and its non-aromatizing nature, making it ideal for research focused on muscle definition, fat metabolism, and tissue preservation. Its propionate ester ensures rapid release and clearance, allowing for flexible, short-cycle research applications.

Manufactured under pharmaceutical-grade standards, Drostanolone Propionate 100 mg/ml is supplied in 10 x 1ml sterile ampoules containing a precise, oil-based solution intended for controlled laboratory and research use only.

Product Details

• Active Ingredient: Drostanolone Propionate

• Concentration per ml: 100 mg

• Form: Injectable solution

• Package Size: 10 x 1ml ampoules

Pharmacokinetics

Drostanolone Propionate has a short half-life of approximately 1–2 days, making it ideal for frequent administration in short-term or intensive research protocols. It delivers pronounced anabolic effects with virtually no estrogenic activity and mild androgenic properties.

Usage Recommendations

• Typical Research Dosage (historical reference): 100 mg every other day

• Current Use: Intended solely for research and laboratory purposes

• Administration: Intramuscular injection

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human medical use or consumption. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with pre-existing health conditions. Always follow local laws and professional handling guidelines.